Summary:
Click image to enlargeA local research group is evaluating the safety and effectiveness of an investigational biological medication for moderate to severe PsA.
Qualified Participants Must:
• Be at least 18 years old or older
• Have been diagnosed with PsA with symptom onset for at least 6 months
• Have diagnosis of plaque psoriasis
• Have demonstrated an inadequate response or intolerance to synthetic disease modifying anti-rheumatic drugs
Qualified Participants May Receive:
Qualified participants may receive reimbursement for time and travel. Study-related care and study-related medication may be provided at no cost.